Literature DB >> 23948876

Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome.

V Phan1, T Blydt-Hansen, J Feber, N Alos, S Arora, S Atkinson, L Bell, C Clarson, R Couch, E A Cummings, G Filler, R M Grant, J Grimmer, D Hebert, B Lentle, J Ma, M Matzinger, J Midgley, M Pinsk, C Rodd, N Shenouda, R Stein, D Stephure, S Taback, K Williams, F Rauch, K Siminoski, L M Ward.   

Abstract

UNLABELLED: Incident vertebral fractures and lumbar spine bone mineral density (BMD) were assessed in the 12 months following glucocorticoid initiation in 65 children with nephrotic syndrome. The incidence of vertebral fractures was low at 12 months (6 %) and most patients demonstrated recovery in BMD Z-scores by this time point.
INTRODUCTION: Vertebral fracture (VF) incidence following glucocorticoid (GC) initiation has not been previously reported in pediatric nephrotic syndrome.
METHODS: VF was assessed on radiographs (Genant method); lumbar spine bone mineral density (LS BMD) was evaluated by dual-energy X-ray absorptiometry.
RESULTS: Sixty-five children were followed to 12 months post-GC initiation (median age, 5.4 years; range, 2.3-17.9). Three of 54 children with radiographs (6 %; 95 % confidence interval (CI), 2-15 %) had incident VF at 1 year. The mean LS BMD Z-score was below the healthy average at baseline (mean ± standard deviation (SD), -0.5 ± 1.1; p = 0.001) and at 3 months (-0.6 ± 1.1; p < 0.001), but not at 6 months (-0.3 ± 1.3; p = 0.066) or 12 months (-0.3 ± 1.2; p = 0.066). Mixed effect modeling showed a significant increase in LS BMD Z-scores between 3 and 12 months (0.22 SD; 95 % CI, 0.08 to 0.36; p = 0.003). A subgroup (N = 16; 25 %) had LS BMD Z-scores that were ≤-1.0 at 12 months. In these children, each additional 1,000 mg/m(2) of GC received in the first 3 months was associated with a decrease in LS BMD Z-score by 0.39 at 12 months (95 % CI, -0.71 to -0.07; p = 0.017).
CONCLUSIONS: The incidence of VF at 1 year was low and LS BMD Z-scores improved by 12 months in the majority. Twenty-five percent of children had LS BMD Z-scores ≤-1.0 at 12 months. In these children, LS BMD Z-scores were inversely associated with early GC exposure, despite similar GC exposure compared to the rest of the cohort.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23948876      PMCID: PMC4100956          DOI: 10.1007/s00198-013-2466-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Population-based assessment of adverse events associated with long-term glucocorticoid use.

Authors:  Jeffrey R Curtis; Andrew O Westfall; Jeroan Allison; Johannes W Bijlsma; Allison Freeman; Varghese George; Stacey H Kovac; Claire M Spettell; Kenneth G Saag
Journal:  Arthritis Rheum       Date:  2006-06-15

Review 2.  Corticosteroid therapy for nephrotic syndrome in children.

Authors:  E M Hodson; J F Knight; N S Willis; J C Craig
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Variations in pattern of pubertal changes in girls.

Authors:  W A Marshall; J M Tanner
Journal:  Arch Dis Child       Date:  1969-06       Impact factor: 3.791

4.  Age-predicted values for lumbar spine, proximal femur, and whole-body bone mineral density: results from a population of normal children aged 3 to 18 years.

Authors:  Colin E Webber; Lesley F Beaumont; Judy Morrison; Alessandra Sala; Ronald D Barr
Journal:  Can Assoc Radiol J       Date:  2007-02       Impact factor: 2.248

5.  Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.

Authors:  T Fujita; A Satomura; M Hidaka; I Ohsawa; M Endo; H Ohi
Journal:  Calcif Tissue Int       Date:  2000-03       Impact factor: 4.333

Review 6.  The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.

Authors:  T P van Staa; H G M Leufkens; C Cooper
Journal:  Osteoporos Int       Date:  2002-10       Impact factor: 4.507

7.  Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version.

Authors:  Cynthia L Ogden; Robert J Kuczmarski; Katherine M Flegal; Zuguo Mei; Shumei Guo; Rong Wei; Laurence M Grummer-Strawn; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

8.  Children and the risk of fractures caused by oral corticosteroids.

Authors:  T P van Staa; C Cooper; H G M Leufkens; N Bishop
Journal:  J Bone Miner Res       Date:  2003-05       Impact factor: 6.741

9.  Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.

Authors:  Mary B Leonard; Harold I Feldman; Justine Shults; Babette S Zemel; Bethany J Foster; Virginia A Stallings
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

10.  Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome.

Authors:  Anne Tsampalieros; Pooja Gupta; Michelle R Denburg; Justine Shults; Babette S Zemel; Sogol Mostoufi-Moab; Rachel J Wetzsteon; Rita M Herskovitz; Krista M Whitehead; Mary B Leonard
Journal:  J Bone Miner Res       Date:  2013-03       Impact factor: 6.741

View more
  20 in total

Review 1.  The Utility of DXA Assessment at the Forearm, Proximal Femur, and Lateral Distal Femur, and Vertebral Fracture Assessment in the Pediatric Population: 2019 ISCD Official Position.

Authors:  David R Weber; Alison Boyce; Catherine Gordon; Wolfgang Högler; Heidi H Kecskemethy; Madhusmita Misra; Diana Swolin-Eide; Peter Tebben; Leanne M Ward; Halley Wasserman; Christopher Shuhart; Babette S Zemel
Journal:  J Clin Densitom       Date:  2019-07-10       Impact factor: 2.617

2.  Common normal variants of pediatric vertebral development that mimic fractures: a pictorial review from a national longitudinal bone health study.

Authors:  Jacob L Jaremko; Kerry Siminoski; Gregory B Firth; Mary Ann Matzinger; Nazih Shenouda; Victor N Konji; Johannes Roth; Anne Marie Sbrocchi; Martin H Reed; Mary Kathleen O'Brien; Helen Nadel; Scott McKillop; Reinhard Kloiber; Josée Dubois; Craig Coblentz; Martin Charron; Leanne M Ward
Journal:  Pediatr Radiol       Date:  2015-04-01

3.  Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS.

Authors:  Gabriella Aceto; Olinda D'Addato; Giovanni Messina; Vincenza Carbone; Luciano Cavallo; Giacomina Brunetti; Maria Felicia Faienza
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

Review 4.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

5.  Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.

Authors:  Claire M A LeBlanc; Jinhui Ma; Monica Taljaard; Johannes Roth; Rosie Scuccimarri; Paivi Miettunen; Bianca Lang; Adam M Huber; Kristin Houghton; Jacob L Jaremko; Josephine Ho; Nazih Shenouda; Mary Ann Matzinger; Brian Lentle; Robert Stein; Anne Marie Sbrocchi; Kiem Oen; Celia Rodd; Roman Jurencak; Elizabeth A Cummings; Robert Couch; David A Cabral; Stephanie Atkinson; Nathalie Alos; Frank Rauch; Kerry Siminoski; Leanne M Ward
Journal:  J Bone Miner Res       Date:  2015-05-26       Impact factor: 6.741

6.  Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.

Authors:  Diana Ribeiro; Sophie Zawadynski; Laure F Pittet; Thierry Chevalley; Eric Girardin; Paloma Parvex
Journal:  Eur J Pediatr       Date:  2015-01-10       Impact factor: 3.183

7.  The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.

Authors:  Sushmita Banerjee; Surupa Basu; Ananda Sen; Jayati Sengupta
Journal:  Pediatr Nephrol       Date:  2017-07-19       Impact factor: 3.714

8.  Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice.

Authors:  Sita Sharan Patel; Malairaman Udayabanu
Journal:  Metab Brain Dis       Date:  2014-01-17       Impact factor: 3.584

Review 9.  The management of osteoporosis in children.

Authors:  L M Ward; V N Konji; J Ma
Journal:  Osteoporos Int       Date:  2016-04-28       Impact factor: 4.507

10.  Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controls.

Authors:  R J Moon; R D Gilbert; A Page; L Murphy; P Taylor; C Cooper; E M Dennison; J H Davies
Journal:  Bone       Date:  2013-10-18       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.